PMID: 7542455Jan 1, 1995Paper

Monoclonal IgM antiphosphatidylserine antibody reacts against cytoskeleton-like structures in cultured human umbilical cord endothelial cells

American Journal of Reproductive Immunology : AJRI
L LinN S Rote

Abstract

It has been proposed that antibodies against phospholipid-dependent antigens (aPLs), induce recurrent pregnancy loss and thrombosis through modulation of endothelial cell function, yet aPLs have not been conclusively shown to bind with endothelial cells. Using indirect immunofluorescence we investigated the anti-endothelial cell reactivity of three monoclonal antibodies that differentiate between the phospholipids cardiolipin (CL) and phosphatidylserine (PS): BA3B5C4 (CL+/PS+); 3SB9b (CL-/PS+); and D11A4 (CL+/PS-). Cultured umbilical cord endothelial cells were prepared without fixation or with cold acetone fixation. None of the aPLs reacted with endothelial cells prepared without fixation. 3SB9B reacted strongly with cytoskeletal-like components in acetone-fixed cells, whereas BA3B5C4 and D11A4 were unreactive. The cytoskeletal-like binding of 3SB9b was completely blocked by a monoclonal antibody against vimentin, whereas antibodies against tubulin or actin were not inhibitory. Lipid extraction of the cells destroyed the 3SB9b reactive antigen without affecting the reactivity of anti-vimentin. These results suggest that phospholipid-dependent antigenic determinants are not expressed on the surface of resting endothelial cells ...Continue Reading

References

May 4, 1978·Biochimica Et Biophysica Acta·C W HaestB Deuticke
Aug 1, 1992·American Journal of Reproductive Immunology : AJRI·N S RoteT W Lyden
Jun 1, 1992·Journal of Reproductive Immunology·T W LydenN S Rote
Oct 1, 1992·The Journal of Cell Biology·M C WagnerJ P Albanesi
Apr 1, 1991·Journal of Muscle Research and Cell Motility·G Isenberg
Feb 1, 1991·Thrombosis Research·L W ChamleyN S Pattison
Jan 1, 1991·Chemistry and Physics of Lipids·M ColleauP F Devaux
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J Rauch, A S Janoff
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H P McNeilS A Krilis
Aug 1, 1990·The Biochemical Journal·M Wolf, M Baggiolini
Feb 28, 1989·Biochemical and Biophysical Research Communications·Q Zhuang, A Stracher
Aug 7, 1989·Biochimica Et Biophysica Acta·P ComfuriusR F Zwaal
Jul 26, 1989·Journal of Immunological Methods·P R Young
Oct 1, 1987·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J R Glenney
May 1, 1986·The New England Journal of Medicine·R CariouJ Caen
May 1, 1986·Clinical Immunology and Immunopathology·D W BranchJ R Scott
Jan 1, 1987·Clinical Immunology and Immunopathology·D W BranchJ R Scott
Mar 28, 1981·Lancet·D MarchesiJ S Cameron
Mar 1, 1993·Clinical Immunology and Immunopathology·N S RoteR Siekman

❮ Previous
Next ❯

Citations

Apr 12, 2003·Progress in Lipid Research·John A McIntyreW Page Faulk
Jan 1, 1995·American Journal of Reproductive Immunology : AJRI·N S RoteT Mori
Apr 2, 1999·American Journal of Reproductive Immunology : AJRI·W H KuttehR Silver
Apr 1, 1996·American Journal of Reproductive Immunology : AJRI·B D KaiderC B Coulam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.